Inhibition of nonsense-mediated RNA decay by ER stress

RNA. 2017 Mar;23(3):378-394. doi: 10.1261/rna.058040.116. Epub 2016 Dec 9.

Abstract

Nonsense-mediated RNA decay (NMD) selectively degrades mutated and aberrantly processed transcripts that contain premature termination codons (PTC). Cellular NMD activity is typically assessed using exogenous PTC-containing reporters. We overcame some inherently problematic aspects of assaying endogenous targets and developed a broadly applicable strategy to reliably and easily monitor changes in cellular NMD activity. Our new method was genetically validated for distinguishing NMD regulation from transcriptional control and alternative splicing regulation, and unexpectedly disclosed a different sensitivity of NMD targets to NMD inhibition. Applying this robust method for screening, we identified NMD-inhibiting stressors but also found that NMD inactivation was not universal to cellular stresses. The high sensitivity and broad dynamic range of our method revealed a strong correlation between NMD inhibition, endoplasmic reticulum (ER) stress, and polysome disassembly upon thapsigargin treatment in a temporal and dose-dependent manner. We found little evidence of calcium signaling mediating thapsigargin-induced NMD inhibition. Instead, we discovered that of the three unfolded protein response (UPR) pathways activated by thapsigargin, mainly protein kinase RNA-like endoplasmic reticulum kinase (PERK) was required for NMD inhibition. Finally, we showed that ER stress compounded TDP-43 depletion in the up-regulation of NMD isoforms that had been implicated in the pathogenic mechanisms of amyotrophic lateral sclerosis and frontotemporal dementia, and that the additive effect of ER stress was completely blocked by PERK deficiency.

Keywords: ALS; ATF6α; FTD; Hnrnpl; IREα; NMD; PERK; Psd-95; Ptbp1; Ptbp2; Srsf11; Tdp-43; Tra2b; UPR; Upf2; alternative splicing; cellular stress; cryptic splicing.

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Alternative Splicing / drug effects*
  • Animals
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cell Line, Tumor
  • Codon, Nonsense
  • DNA-Binding Proteins / deficiency
  • DNA-Binding Proteins / genetics
  • Disks Large Homolog 4 Protein
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / genetics
  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum Stress / drug effects*
  • Enzyme Inhibitors / pharmacology
  • Guanylate Kinases / genetics
  • Guanylate Kinases / metabolism
  • Heterogeneous-Nuclear Ribonucleoproteins / genetics
  • Heterogeneous-Nuclear Ribonucleoproteins / metabolism
  • High-Throughput Screening Assays
  • Indoles / pharmacology
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Knockout
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Polypyrimidine Tract-Binding Protein / genetics
  • Polypyrimidine Tract-Binding Protein / metabolism
  • Protein Kinase Inhibitors / pharmacology*
  • RNA Stability / drug effects*
  • RNA-Binding Proteins
  • Signal Transduction
  • Thapsigargin / pharmacology*
  • eIF-2 Kinase / antagonists & inhibitors
  • eIF-2 Kinase / genetics
  • eIF-2 Kinase / metabolism

Substances

  • 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine
  • Carrier Proteins
  • Codon, Nonsense
  • DNA-Binding Proteins
  • Disks Large Homolog 4 Protein
  • Dlg4 protein, mouse
  • Enzyme Inhibitors
  • Heterogeneous-Nuclear Ribonucleoproteins
  • Indoles
  • Membrane Proteins
  • Nerve Tissue Proteins
  • Protein Kinase Inhibitors
  • Ptbp1 protein, mouse
  • Ptbp2 protein, mouse
  • RNA-Binding Proteins
  • TDP-43 protein, mouse
  • Upf2 protein, mouse
  • Polypyrimidine Tract-Binding Protein
  • Thapsigargin
  • PERK kinase
  • eIF-2 Kinase
  • Guanylate Kinases
  • Adenine